-
HC Wainwright Reaffirms "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM)
来源: Buzz FX / 03 2月 2025 08:51:09 America/New_York
HC Wainwright Reaffirms "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM) Written by MarketBeat February 3, 2025 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "buy" rating reaffirmed by
Read more...